BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32284541)

  • 1. Single-cell EMT-related transcriptional analysis revealed intra-cluster heterogeneity of tumor cell clusters in epithelial ovarian cancer ascites.
    Kan T; Wang W; Ip PP; Zhou S; Wong AS; Wang X; Yang M
    Oncogene; 2020 May; 39(21):4227-4240. PubMed ID: 32284541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells.
    Pakuła M; Mikuła-Pietrasik J; Witucka A; Kostka-Jeziorny K; Uruski P; Moszyński R; Naumowicz E; Sajdak S; Tykarski A; Książek K
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
    Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
    BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
    Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
    BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.
    Kim S; Lee M; Dhanasekaran DN; Song YS
    BMC Cancer; 2018 Dec; 18(1):1232. PubMed ID: 30526541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.
    Ho CM; Chang SF; Hsiao CC; Chien TY; Shih DT
    J Biomed Sci; 2012 Feb; 19(1):23. PubMed ID: 22330345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.
    Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
    Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.
    Carduner L; Leroy-Dudal J; Picot CR; Gallet O; Carreiras F; Kellouche S
    Clin Exp Metastasis; 2014 Aug; 31(6):675-88. PubMed ID: 24946950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.
    Uruski P; Mikuła-Pietrasik J; Pakuła M; Budkiewicz S; Drzewiecki M; Gaiday AN; Wierzowiecka M; Naumowicz E; Moszyński R; Tykarski A; Książek K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 13. TGFβ signaling networks in ovarian cancer progression and plasticity.
    Kumari A; Shonibare Z; Monavarian M; Arend RC; Lee NY; Inman GJ; Mythreye K
    Clin Exp Metastasis; 2021 Apr; 38(2):139-161. PubMed ID: 33590419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts.
    Dong T; Yang D; Li R; Zhang L; Zhao H; Shen Y; Zhang X; Kong B; Wang L
    Exp Mol Pathol; 2016 Feb; 100(1):17-25. PubMed ID: 26607602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer.
    Al Habyan S; Kalos C; Szymborski J; McCaffrey L
    Oncogene; 2018 Sep; 37(37):5127-5135. PubMed ID: 29789717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
    Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
    Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor-β1 expression.
    Liang S; Yao Q; Wei D; Liu M; Geng F; Wang Q; Wang YS
    J Cell Biochem; 2019 Jan; 120(1):493-506. PubMed ID: 30277596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
    Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.